Your browser doesn't support javascript.
loading
YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango.
Matthaios, Dimitrios; Tolia, Maria; Mauri, Davide; Kamposioras, Konstantinos; Karamouzis, Michalis.
Afiliação
  • Matthaios D; Department of Medical Oncology, Rhodes General Hospital, 85100 Rhodes, Greece.
  • Tolia M; Department of Radiotherapy, School of Medicine, University of Crete, 71500 Heraklion, Greece.
  • Mauri D; Department of Medical Oncology, University of Ιoannina, 45110 Ιoannina, Greece.
  • Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
  • Karamouzis M; Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Biomedicines ; 9(12)2021 Dec 20.
Article em En | MEDLINE | ID: mdl-34944765
ABSTRACT
Hippo pathway with its main molecule YAP is a crucial pathway for development, tissue homeostasis, wound healing, tissue regeneration, and cancer. In this review, we discuss the multiple effects of the YAP/Hippo pathway in the immune system and cancer. We analyzed a series of effects extracellular vesicles enhanced immunity through inhibition of LATS1/2, ways of modulation of the tumor microenvironment, YAP- and TAZ-mediated upregulation of PDL1, high expression of YAP and PDL1 in EGFR-TKI-resistant cells, enhanced YAP activity in inflammation, and the effect of the Hippo pathway on T cells, B cells, Tregs, macrophages, and myeloid-derived suppressor cells (MDSCs). These pleiotropic effects render the YAP and Hippo pathway a key pathway for exploitation in the future, in order to enhance our immunotherapy treatment strategies in oncology.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article